ImmunoPrecise Antibodies ...

NASDAQ: IPA · Real-Time Price · USD
3.20
0.57 (21.67%)
At close: Aug 22, 2025, 3:59 PM
3.22
0.63%
After-hours: Aug 22, 2025, 07:56 PM EDT

ImmunoPrecise Antibodies Cash Flow Statement

Financials in CAD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Aug 9, 2023 Apr 30, 2023 Jan 31, 2023 Dec 13, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Net Income
-2.16M -21.52M -2.55M -4M -18.05M -2.94M -2.63M -9.38M -5.13M -4.7M -7.35M -9.38M -4.64M -3.83M -5.01M -3.23M -5.03M -1.29M -463.58K -549.32K
Depreciation & Amortization
913K 1.4M 1.41M 1.4M 1.58M 1.31M 1.35M 1.55M 1.98M 1.69M 1.46M 1.55M 926K 949K 937K 957K 891.15K 936.19K 973.74K 911.92K
Stock-Based Compensation
53K 70K 157K 165K 237K 1M 1.12M 823K 636K 193K 355K 759K 786K 492K 689K 1.12M 1.32M 852.58K 476.57K 97.27K
Other Working Capital
-202K 197K n/a -71K -282K 23K 576K -2.78M -393K -88K -438K -57K 649K -2.76M 881K 141K -1.05M -483.79K 230.41K 492.94K
Other Non-Cash Items
465K 21.09M 97K 158K 4K 5K -59K -15K 2.48M 67K -228K -15K 295K -381K 181K -405K 1.37M 13.3K -218.42K 101.14K
Deferred Income Tax
n/a -2.96M -330K -645K -1.19M -166K -200K -261K -250K -258K -157K -261K -922K 843K -162K -95K 210.98K -99.98K -194K 110.93K
Change in Working Capital
-410K 723K -649K 1.1M -174K 899K 1M -2.97M -1.95M -535K 2.18M -2.97M 1.77M -3.23M 1.35M 692K 504.4K -1.12M -134.08K -263.57K
Operating Cash Flow
-1.14M -1.2M -2.24M -1.82M -2.64M -666K -235K -10.31M -2.23M -3.54M -3.74M -10.31M -1.79M -5.16M -2.01M -965K -731.56K -717.05K 440.23K 408.38K
Capital Expenditures
-359K -112K -65K -263K -1.13M 165K -299K -89K -462K -245K -699K -89K -333K -473K -111K -340K -307.38K -372.79K -715.21K -31.61K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -146K 18K n/a -610K n/a -3.69M n/a n/a n/a -510.47K n/a n/a -518.53K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 549K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a 36K 85K n/a 19K 61K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 99K n/a 16K -108K -49K 61K n/a 19K -509K n/a -68K -191K n/a n/a 270K 9K -258K -21K
Investing Cash Flow
-359K -112K -65K -263K -1.11M 57K -312K -89K -444K -226K -1.21M -89K -4.09M -664K -111K -340K -817.85K -372.79K -715.21K -550.15K
Debt Repayment
-435K -158K n/a 2.21M -302K -322K -310K -405K -382K -379K -305K -271K -260K -237K -229K -236K -248.67K -136K -306K -81K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 2.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a -5K 186K n/a 26K n/a n/a -355 3.65M
Financial Cash Flow
-418K 10.55M 2.07M 2.7M 1.12M 613K -310K -152K -381K -282K 194K -152K 3.06M -51K 82K -210K 28.75M 94.73K 10.97M 3.57M
Net Cash Flow
-2.21M 9.38M -379K 455K -2.74M 185K -709K -10.72M -3.04M -3.74M -4.18M -10.72M -3.02M -5.37M -2.34M -1.06M 26.04M -1.12M 10.78M 3.46M
Free Cash Flow
-1.5M -1.31M -2.31M -2.09M -3.77M -501K -534K -10.4M -2.7M -3.79M -4.44M -10.4M -2.12M -5.63M -2.12M -1.3M -1.04M -1.09M -274.98K 376.77K